These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1347054)

  • 1. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.
    Roos MT; Lange JM; de Goede RE; Coutinho RA; Schellekens PT; Miedema F; Tersmette M
    J Infect Dis; 1992 Mar; 165(3):427-32. PubMed ID: 1347054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1.
    Connor RI; Paxton WA; Sheridan KE; Koup RA
    J Virol; 1996 Dec; 70(12):8758-64. PubMed ID: 8971004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.
    Spencer LT; Ogino MT; Dankner WM; Spector SA
    J Infect Dis; 1994 Mar; 169(3):491-5. PubMed ID: 7908924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection.
    Koot M; van 't Wout AB; Kootstra NA; de Goede RE; Tersmette M; Schuitemaker H
    J Infect Dis; 1996 Feb; 173(2):349-54. PubMed ID: 8568295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Koot M; Keet IP; Vos AH; de Goede RE; Roos MT; Coutinho RA; Miedema F; Schellekens PT; Tersmette M
    Ann Intern Med; 1993 May; 118(9):681-8. PubMed ID: 8096374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.
    Blaak H; van't Wout AB; Brouwer M; Hooibrink B; Hovenkamp E; Schuitemaker H
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1269-74. PubMed ID: 10655520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity and diversity of HIV and implications for clinical management: a review.
    Saag MS; Hammer SM; Lange JM
    J Acquir Immune Defic Syndr (1988); 1994; 7 Suppl 2():S2-10; discussion S10-1. PubMed ID: 7965648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease.
    Nicastri E; Ercoli L; Sarmati L; Ventura L; Parisi SG; Ciapetti C; Montano M; Andreoni M
    J Hum Virol; 1998; 1(2):90-5. PubMed ID: 10195237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo.
    Fouchier RA; Meyaard L; Brouwer M; Hovenkamp E; Schuitemaker H
    Virology; 1996 May; 219(1):87-95. PubMed ID: 8623557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.
    Jansson M; Popovic M; Karlsson A; Cocchi F; Rossi P; Albert J; Wigzell H
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15382-7. PubMed ID: 8986820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1.
    Yu X; McLane MF; Ratner L; O'Brien W; Collman R; Essex M; Lee TH
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10237-41. PubMed ID: 7937869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.
    van't Wout AB; Ran LJ; de Jong MD; Bakker M; van Leeuwen R; Notermans DW; Loeliger AE; de Wolf F; Danner SA; Reiss P; Boucher CA; Lange JM; Schuitemaker H
    J Clin Invest; 1997 Nov; 100(9):2325-32. PubMed ID: 9410911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1.
    Glushakova S; Baibakov B; Zimmerberg J; Margolis LB
    AIDS Res Hum Retroviruses; 1997 Apr; 13(6):461-71. PubMed ID: 9100987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users.
    Yu XF; Wang Z; Vlahov D; Markham RB; Farzadegan H; Margolick JB
    J Infect Dis; 1998 Aug; 178(2):388-96. PubMed ID: 9697718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
    van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H
    J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of syncytium-inducing and non-syncytium-inducing type 1 human immunodeficiency viruses during primary infection.
    Rodrigo AG
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1447-51. PubMed ID: 9390743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
    Forte SE; Byron KS; Sullivan JL; Somasundaran M
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1613-8. PubMed ID: 7888220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.
    Richman DD; Bozzette SA
    J Infect Dis; 1994 May; 169(5):968-74. PubMed ID: 7909549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.